The overwhelming majority of the VC funding, 80%, is being imported into the region from investment firms located elsewhere.
Image: Philadelphia Alliance for Capital & Technologies CEO Dean Miller discusses the capital investment landscape during the 2019 Regional Biotechnology Conference. JOHN GEORGE
